Retour
67
Fourchette du Jour
17,35 €
17,89 €
Fourchette 52 Semaines
11,63 €
23,87 €
Volume
1 533 507
Moyenne 50J / 200J
20,42 €
/
17,32 €
Clôture Précédente
17,42 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -4960,7 | 0,2 |
| P/B | 20,0 | 3,0 |
| ROE % | -0,5 | 3,6 |
| Net Margin % | 0,0 | 3,8 |
| Rev Growth 5Y % | 35,6 | 9,9 |
| D/E | 1,9 | 0,2 |
Objectif de Cours des Analystes
Hold
24,50 €
+39.4%
Low: 18,00 €
High: 30,00 €
P/E Prévisionnel
133,69
BPA Prévisionnel
0,13 €
Croissance BPA (est.)
+0,0%
CA Est.
5,18B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,71 €
1,64 € – 1,80 €
|
13,89B | 1 |
| FY2029 |
1,29 €
1,24 € – 1,36 €
|
10,53B | 1 |
| FY2028 |
0,73 €
0,52 € – 0,86 €
|
7,99B | 5 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-26 | -0,15 € | -0,05 € | +67,5% |
| 2025-10-30 | -0,01 € | 0,02 € | +300,0% |
| 2025-07-30 | -0,07 € | 0,07 € | +200,0% |
| 2025-05-01 | -0,12 € | -0,05 € | +58,3% |
| 2025-02-27 | -0,18 € | -0,16 € | +11,1% |
| 2024-10-29 | -0,14 € | -0,14 € | 0,0% |
| 2024-08-01 | -0,14 € | -0,13 € | +7,1% |
| 2024-05-02 | -0,24 € | -0,25 € | -4,2% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 35,60% annually over 5 years — strong growth
Generating 113,15M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 10,46%
Capital efficient — spends only 0,68% of revenue on capex
ROIC of 2,14% — low return on invested capital
Interest coverage of 0,93× — tight debt servicing
Croissance
Revenue Growth (5Y)
35,60%
Revenue (1Y)46,06%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-0,52%
ROIC2,14%
Net Margin-0,02%
Op. Margin0,37%
Sécurité
Debt / Equity
1,89
Current Ratio1,74
Interest Coverage0,93
Valorisation
P/E Ratio
-4960,68
Forward P/E133,69
P/B Ratio20,03
EV/EBITDA227,20
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 46,06% | Revenue Growth (3Y) | 47,15% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 35,60% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 3,95B | Net Income (TTM) | -724 000,0 |
| ROE | -0,52% | ROA | -0,07% |
| Gross Margin | 12,37% | Operating Margin | 0,37% |
| Net Margin | -0,02% | Free Cash Flow (TTM) | 113,15M |
| ROIC | 2,14% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1,89 | Current Ratio | 1,74 |
| Interest Coverage | 0,93 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -4960,68 | Forward P/E | 133,69 |
| P/B Ratio | 20,03 | P/S Ratio | 0,91 |
| PEG Ratio | 54,31 | Forward PEG | N/A |
| EV/EBITDA | 227,20 | Fwd EV/EBITDA | N/A |
| Forward P/S | 0,69 | Fwd Earnings Yield | 0,75% |
| FCF Yield | 3,15% | ||
| Market Cap | 3,59B | Enterprise Value | 3,35B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3,95B | 2,70B | 1,82B | 1,43B | 1,17B |
| Net Income | -724 000,0 | -128,04M | -148,02M | -149,55M | -195,29M |
| EPS (Diluted) | 0,00 | -0,67 | -0,79 | -0,83 | -1,14 |
| Gross Profit | 488,56M | 296,69M | 201,03M | 184,28M | 128,73M |
| Operating Income | 14,75M | -101,56M | -127,82M | -128,64M | -178,07M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,07B | 782,06M | 591,88M | 633,86M | 630,90M |
| Total Liabilities | 886,51M | 681,11M | 433,81M | 394,56M | 324,84M |
| Shareholders' Equity | 179,28M | 99,85M | 156,95M | 238,13M | 306,04M |
| Total Debt | 338,07M | 329,26M | 170,79M | 164,60M | 157,60M |
| Cash & Equivalents | 577,94M | 432,86M | 202,90M | 409,55M | 466,60M |
| Current Assets | 831,14M | 661,64M | 483,54M | 544,55M | 552,86M |
| Current Liabilities | 476,53M | 351,85M | 263,02M | 229,96M | 167,25M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#96 of 619
Activité Récente
Entré
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026